Dr. Stephen Salloway

Biography

Stephen Salloway, MD, MS, is the founding Director of the Memory Aging Program at Butler Hospital and a Professor of Psychiatry and Human Behavior and Neurology at the Warren Alpert Medical School of Brown University. He received his MD from Stanford Medical School and completed residency training in neurology and psychiatry at Yale University. Dr. Salloway’s research concentrates on biomarker drug development and prevention of early treatment in Alzheimer’s disease (AD). Under his leadership, the Butler Hospital Memory Aging Program has become recognized internationally as a center for clinical research on Alzheimer’s disease, pioneering the use of PET ligands to explore the evolution of AD pathophysiology. Dr. Salloway has published over 370 scientific articles and abstracts and edited three books, assisting in pivotal clinical trials published in top journals like the New England Journal of Medicine and Lancet. He is a past president of the American Neuropsychiatric Association and serves on several steering committees for significant NIH studies related to Alzheimer’s disease. Dr. Salloway's work aims to enhance strategies for AD prevention through genetic testing and advanced brain imaging techniques, significantly contributing to Alzheimer's research.

Research Interests

Experience